London, UK — March 28, 2025 — Panda Surgical, a medical technology company developing advanced handheld robotic systems for neurosurgery, today announced that it has been granted two new patents by the United States Patent and Trademark Office covering key aspects of its proprietary surgical robotics platform.

The newly issued patents further expand Panda Surgical’s global intellectual property portfolio, protecting core innovations in its next-generation handheld robotic platform and providing a strong competitive advantage in the field of robotic surgery.

‘Securing these patents on our handheld robotic system for neurosurgery reinforces our commitment to safeguarding and advancing our innovative technology. Intellectual property protection is crucial in ensuring we can keep pioneering with confidence and clarity.’

- Manios Dimitrakakis, Panda Surgical CEO

About Panda Surgical

Panda Surgical, a University College London spinout, is developing the world’s first dexterous robot for minimally invasive neurosurgery, offering surgeons enhanced dexterity and decision-support making these complex operations safer, more effective, and more widely adopted.

‍